[go: up one dir, main page]

DE3585681D1 - Diaetzusatz zur verminderung der gefahr einer infektion. - Google Patents

Diaetzusatz zur verminderung der gefahr einer infektion.

Info

Publication number
DE3585681D1
DE3585681D1 DE8585903749T DE3585681T DE3585681D1 DE 3585681 D1 DE3585681 D1 DE 3585681D1 DE 8585903749 T DE8585903749 T DE 8585903749T DE 3585681 T DE3585681 T DE 3585681T DE 3585681 D1 DE3585681 D1 DE 3585681D1
Authority
DE
Germany
Prior art keywords
infection
diet
omega
rich
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585903749T
Other languages
English (en)
Inventor
Edward A Mascioli
George L Blackburn
Bruce R Bistrian
Vigen K Babayan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24528374&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3585681(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3585681D1 publication Critical patent/DE3585681D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8585903749T 1984-07-12 1985-07-11 Diaetzusatz zur verminderung der gefahr einer infektion. Expired - Lifetime DE3585681D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/630,732 US4752618A (en) 1984-07-12 1984-07-12 Method of minimizing efects of infection through diet
PCT/US1985/001332 WO1986000523A1 (en) 1984-07-12 1985-07-11 Dietary supplement and method of minimizing effects of infection through diet

Publications (1)

Publication Number Publication Date
DE3585681D1 true DE3585681D1 (de) 1992-04-23

Family

ID=24528374

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585903749T Expired - Lifetime DE3585681D1 (de) 1984-07-12 1985-07-11 Diaetzusatz zur verminderung der gefahr einer infektion.

Country Status (7)

Country Link
US (2) US4752618A (de)
EP (1) EP0188573B1 (de)
JP (1) JPH0759508B2 (de)
AT (1) ATE73658T1 (de)
AU (2) AU604633B2 (de)
DE (1) DE3585681D1 (de)
WO (1) WO1986000523A1 (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225441A (en) * 1987-06-18 1993-07-06 Block Drug Company, Inc. Treatment of periodontal disease
IE63225B1 (en) * 1988-09-13 1995-04-05 Efamol Holdings Use of fatty acids in the treatment of myalgic encephalomyelitis
US4981844A (en) * 1988-10-04 1991-01-01 University Of Cincinnati Method to improve immune response and resistance to infection following surgery by diet composition
US5055446A (en) * 1988-10-21 1991-10-08 University Of Cincinnati Method to improve survival of patients during sepsis by diet composition
US5231085A (en) * 1988-10-31 1993-07-27 Sandoz Ltd. Compositions and methods for the enhancement of host defense mechanisms
US5576351A (en) * 1989-12-29 1996-11-19 Mcgaw, Inc. Use of arginine as an immunostimulator
US5407957A (en) * 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
US5089268A (en) * 1990-05-02 1992-02-18 Katz David P Egg phosphatide lipid emulsions altered for a specific therapeutic fatty acid composition
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
GB9026648D0 (en) * 1990-12-07 1991-01-23 Efamol Holdings Nutrition
US5922345A (en) * 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
EP0715853A1 (de) * 1991-01-10 1996-06-12 Transcend Therapeutics, Inc. Verwendung von Glutathionester zur Behandlung von Lungenerkrankungen
ATE200619T1 (de) * 1991-01-24 2001-05-15 Martek Corp Mikrobielle öle und ihre verwendungen
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
SE9101642D0 (sv) * 1991-05-30 1991-05-30 Kabi Pharmacia Ab Phospholipids
AU2190692A (en) * 1991-06-07 1993-01-12 Martek Corporation Brain lipid extracts and method for the production and use thereof
JPH05163160A (ja) * 1991-12-13 1993-06-29 Snow Brand Milk Prod Co Ltd 免疫低下に伴う感染症の予防及び治療用栄養剤
US5278149A (en) * 1992-01-17 1994-01-11 New England Deaconess Hospital Corporation Method of preparing total parenteral nutrition solutions
SE9200541D0 (sv) * 1992-02-24 1992-02-24 Kabi Pharmacia Ab New usee of omega-3-fatty acids
US5261586A (en) * 1992-03-26 1993-11-16 Chen Jen Fu Yarn feeding device with a guiding flange
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
US5260336A (en) * 1992-04-30 1993-11-09 New England Deaconess Hospital Corporation Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness
US5356873A (en) * 1992-11-05 1994-10-18 Clintec Nutrition Co. Method for providing nutritional requirements to patients having a chronic inflammation reaction
WO1994015464A1 (en) * 1993-01-15 1994-07-21 Abbott Laboratories Structured lipids
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
US5438042B1 (en) * 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
US5484623A (en) * 1994-01-10 1996-01-16 Mclean; Linsey Dietary system high in oil intake for the treatment of obesity and for the lowering of saturated fats
US5855949A (en) * 1994-01-10 1999-01-05 Mclean; Linsey Dietary system high in oil intake
JPH10500937A (ja) * 1994-02-25 1998-01-27 ニュー イングランド ディーコネス ホスピタル コーポレイション セサミン系リグナンの抗炎症及び感染防護効果
US5397778A (en) * 1994-02-25 1995-03-14 New England Deaconess Hospital Corporation Enteral formulations for treatment of inflammation and infection
GB9403935D0 (en) * 1994-03-01 1994-04-20 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5574065A (en) * 1994-04-21 1996-11-12 Clintec Nutrition Co. Method and composition for normalizing injury response
US6974796B1 (en) 1999-08-17 2005-12-13 Girsh Leonard S Therapeutic compositions for treatment of a damaged tissue
US20070231402A1 (en) * 1994-08-02 2007-10-04 Immunopath Profile, Inc. Therapeutic stem cell composition and stimulant, facilitator, accelerator, and synergizer thereof, growth factor, anti-inflammatory composition and uses thereof
GB9419345D0 (en) * 1994-09-26 1994-11-09 Sandoz Nutrition Ltd Organic compounds
EP0843972B1 (de) * 1996-11-20 2002-07-31 N.V. Nutricia Fette enthaltende Ernährungszusammensetzung zur Behandlung des Stoffwechselssyndroms
US5993221A (en) * 1997-05-01 1999-11-30 Beth Israel Deaconess Medical Center, Inc. Dietary formulation comprising arachidonic acid and methods of use
US6194379B1 (en) 1998-05-01 2001-02-27 Abbott Laboratories Elemental enteral formula
KR100341109B1 (ko) * 1999-03-10 2002-06-20 이인수 인식력 및 기억력 증강용 식이 조성물
CN1272024C (zh) * 1999-07-09 2006-08-30 太阳农场股份有限公司 使用食物添加剂制备治疗恶性肿瘤和病毒感染以及增进免疫功能的药剂的用途
US7790678B1 (en) 1999-08-17 2010-09-07 Immunopath Profile, Inc. Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy and anti-cancer activity and methods of use
US20090274660A1 (en) * 1999-08-17 2009-11-05 Immunopath Profile, Inc. Pluripotent therapeutic compositions and uses thereof
US20070037777A1 (en) * 2005-08-12 2007-02-15 Immunopath Profile, Inc. Lipid-containing compositions and methods of using them
CA2388754C (en) * 1999-10-13 2010-07-13 Marco A. Chacon Therapeutic intervention to mimic the effect of caloric restriction
EP1294236B1 (de) * 2000-06-01 2008-08-13 United Feeds, Inc. Tiernahrung sowie verfahren
WO2002069964A1 (en) * 2001-03-05 2002-09-12 Ernest Stephen P Enteral formulation
US7988989B2 (en) * 2003-05-09 2011-08-02 Freedom Health, Llc Nutritional product for enhancing growth and/or strengthening the immune system of equine foals
US7658964B2 (en) * 2003-05-09 2010-02-09 Freedom Health, Llc Dietary supplement and method for increasing the colostrum immunoglobulin levels in equine mares
US20050058671A1 (en) * 2003-05-09 2005-03-17 Bedding Peter M.J. Dietary supplement and method for treating digestive system-related disorders
US7824706B2 (en) * 2003-05-09 2010-11-02 Freedom Health, Llc Dietary supplement and method for the treatment of digestive tract ulcers in equines
EP1665940A4 (de) * 2003-09-02 2011-01-19 Bbk Bio Corp Lebensmittelpräparat
EP1684739A4 (de) * 2003-11-12 2006-12-06 Childrens Medical Center Behandlung und prävention von lebererkrankungen im zusammenhang mit parenteraler ernährung (pn)
CA2688293A1 (en) 2007-05-25 2008-12-04 Childrens's Medical Center Corporation Dietary formulations and methods for treatment of inflammation and other disorders
CA2702577A1 (en) 2007-10-15 2009-04-23 Jbs United, Inc. Method for increasing performance of offspring
US20100323028A1 (en) * 2007-11-30 2010-12-23 Jbs United, Inc. Method and composition for treating pulmonary hemorrhage
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8241672B2 (en) * 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
WO2011103512A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha free fatty acid emulsions
WO2011103514A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha triglyceride emulsions
WO2011103510A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha ester emulsions
US20110223246A1 (en) * 2010-03-10 2011-09-15 Joar Opheim Docosahexaenoic acid bound in phospholipids and method of recovering same from a natural source
JP5710150B2 (ja) * 2010-04-08 2015-04-30 持田製薬株式会社 潜伏性感染疾患の再発抑制剤
CN117918525A (zh) 2017-08-10 2024-04-26 儿童医疗中心有限公司 与包含鱼油和/或ω-3脂肪酸的乳剂有关的方法和组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2977283A (en) * 1956-04-30 1961-03-28 Upjohn Co Therapeutic intravenous fat compositions
DE2533612A1 (de) * 1974-08-19 1976-03-04 Pharmacia Ab Parenteral verabreichbares oel und verfahren zu seiner herstellung
AU527784B2 (en) * 1978-05-26 1983-03-24 Bang, Hans Olaf Dr. Treatment of thromboembolic conditions withall-z)-5, 8, 11, 14, 17-eicosapentaenoic acid
JPS57169416A (en) * 1981-04-14 1982-10-19 Nippon Suisan Kaisha Ltd Health food
GB2098065A (en) * 1981-04-14 1982-11-17 Nippon Suisan Kaisha Ltd Antithrombotic compositions containing docosahexaenoic acid
EP0092076B1 (de) * 1982-04-16 1986-12-17 Societe Des Produits Nestle S.A. Lipidhaltige Zusammensetzung für die orale, enterale oder parenterale Ernährung
GB2134782B (en) * 1982-09-22 1987-03-04 Sentrachem Ltd Anti-cancer compositions containing higher fatty acids
JPS59172416A (ja) * 1983-03-18 1984-09-29 Terumo Corp 脂肪輸液
JPH0615469B2 (ja) * 1984-05-09 1994-03-02 テルモ株式会社 脂肪輸液剤
US4678808A (en) * 1985-10-15 1987-07-07 Baxter Travenol Laboratories, Inc. Rapid acting intravenous emulsions of omega-3 fatty acid esters

Also Published As

Publication number Publication date
EP0188573A4 (de) 1987-03-30
EP0188573B1 (de) 1992-03-18
ATE73658T1 (de) 1992-04-15
US4752618A (en) 1988-06-21
JPS61502816A (ja) 1986-12-04
US4820731A (en) 1989-04-11
AU604633B2 (en) 1991-01-03
AU6375190A (en) 1991-05-09
AU4632685A (en) 1986-02-10
EP0188573A1 (de) 1986-07-30
JPH0759508B2 (ja) 1995-06-28
AU628662B2 (en) 1992-09-17
WO1986000523A1 (en) 1986-01-30

Similar Documents

Publication Publication Date Title
DE3585681D1 (de) Diaetzusatz zur verminderung der gefahr einer infektion.
TNSN86111A1 (fr) Procede de preparation d'hydroxyalkylxanthines tertiaires
MX168000B (es) Complemento dietetico que contiene beta-glucan complemento
FI881647A0 (fi) Menetelmä rasvavalmisteen valmistamiseksi
DE3675796D1 (de) Verfahren zur herstellung von entschleimten pflanzlichen oelen und schleim mit hohem gehalt an phosphatidischer saeure.
ATE128352T1 (de) Diät zur besserem ueberleben von kranken mit sepsis.
FR2618332B1 (fr) Emulsion lipidique destinee a la nutrition parenterale ou enterale
ES8705748A1 (es) Un procedimiento para la preparacion de una formula alimenticia baja en hidratos de carbono y alta en grasas.
GB2182942B (en) Improvements in and relating to margarine and like fat compositions
ZA851046B (en) Method for directed visceral metabolism of medium chain triglycerides
DE3268400D1 (en) Fat emulsion for parenteral nutrition
SE8800989L (sv) Dietkomposition samt foerfarande foer framstaellning av densamma
SE8800988D0 (sv) Pharmaceutical compositons acting on the heart and cardiovascular system and process for preparing same
SE8800990L (sv) Hudregenererande kosmetisk komposition samt foerfarande foer framstaellning av densamma
JPS617191B2 (de)
PT89654A (pt) Processo para a preparacao de composicoes que contem gorduras com um baixo conteudo de fosfatidos
BE901206A (fr) Emulsion pour transfusion.
ATE12164T1 (de) Arzneimittel enthaltend proteinhydrolysate und an polyungesaettigten fettsaeuren reiche lipide.
ATE189579T1 (de) Essbares fettprodukt und darin verwendetes umgeestertes fett
SE8800101D0 (sv) Anvendning av essentiella fettsyror for framstellning av ett preparat for behandling av eksem
KR930022964A (ko) n-3 지방산 비율이 높은 닭고기 및 육계용 사료조성물
IT8423328A0 (it) Procedimento per la realizzazione di un prosciutto cotto, a base di vitello, vitellone, manzo, utilizzabile anche, con l'eventuale aggiunta di lingua salmistrata edi altri prodotti, per creare varie composizioni alimentari.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation